Nomura Holdings
JAZZ icon

Nomura Holdings’s Jazz Pharmaceuticals JAZZ Stock Holding History

Nomura Holdings’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-100,000
Closed -$14.5M – 1528
2017
Q1 		$14.5M Buy
+100,000
New +$13M 0.04% 214

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Nomura Holdings's JAZZ Position: Q1 2026 in Review

Nomura Holdings increased its Jazz Pharmaceuticals (JAZZ) stake by 0.11% in Q1 2026, buying an estimated $11.7K and bringing the position to 60,151 shares worth $11.4M. The position accounts for 0.03% of the portfolio, ranked #397.

Nomura Holdings first reported a position in JAZZ in Q2 2013 and has held it in 36 quarters since. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Nomura Holdings held 60,151 shares of Jazz Pharmaceuticals worth $11.4M as of Q1 2026.
  • Nomura Holdings bought 67 Jazz Pharmaceuticals shares in Q1 2026, an estimated $11.7K.
  • Jazz Pharmaceuticals made up 0.03% of Nomura Holdings's portfolio in Q1 2026, its #397 holding.
  • Nomura Holdings first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 36 quarters since.
  • 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.